Incyte (INCY) EBITDA Margin (2016 - 2025)
Historic EBITDA Margin for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to 22.29%.
- Incyte's EBITDA Margin fell 32900.0% to 22.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 29.46%, marking a year-over-year increase of 280200.0%. This contributed to the annual value of 29.46% for FY2025, which is 280200.0% up from last year.
- Incyte's EBITDA Margin amounted to 22.29% in Q4 2025, which was down 32900.0% from 32.47% recorded in Q3 2025.
- Incyte's EBITDA Margin's 5-year high stood at 43.63% during Q2 2025, with a 5-year trough of 45.81% in Q2 2024.
- Moreover, its 5-year median value for EBITDA Margin was 18.98% (2023), whereas its average is 16.62%.
- Its EBITDA Margin has fluctuated over the past 5 years, first soared by 1331400bps in 2021, then crashed by -661100bps in 2024.
- Incyte's EBITDA Margin (Quarter) stood at 12.83% in 2021, then crashed by -41bps to 7.56% in 2022, then soared by 144bps to 18.48% in 2023, then surged by 38bps to 25.58% in 2024, then fell by -13bps to 22.29% in 2025.
- Its last three reported values are 22.29% in Q4 2025, 32.47% for Q3 2025, and 43.63% during Q2 2025.